Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.

Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2. No substantive changes to the study details are evident.SummaryDifference0.1%

- Check28 days agoChange DetectedThe notice about potential delays due to lapse in government funding has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedNo significant changes detected in the study record; observed updates are limited to minor formatting and non-critical textual edits that do not affect eligibility, endpoints, or trial status, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedPage now includes a government-funding notice about possible delays and updated operating status links, and the version has been upgraded to v3.2.0 (removing v3.1.0).SummaryDifference2%

- Check78 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive changes.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the 'Back to Top' link was removed. No other substantive content changes are observed.SummaryDifference0.1%

Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.